Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Kim HJ, Jang BH, Kim MJ, Kim KC, Kuon WJ, Kim CK. Prevalence of and associations between metabolic syndrome and the constitutions defined by Korean Eight Constitution Medicine. Medicine (Baltimore). 2020;99(7):e19074. doi:10.1097/MD.0000000000019074.
Lozano-Cuenca J, Valencia-Hernández I, López-Canales OA, et al. Possible mechanisms involved in the effect of the subchronic administration of rosuvastatin on endothelial function in rats with metabolic syndrome. Braz J Med Biol Res. 2020;53(2):e9304. doi:10.1590/1414-431X20199304.
Li RC, Zhang L, Luo H, et al. Subclinical hypothyroidism and anxiety may contribute to metabolic syndrome in Sichuan of China: a hospital-based population study. Sci Rep. 2020;10(1):2261. doi:10.1038/s41598-020-58973-w.
Seo YR, Kim JS, Kim SS, Jung JG, Yoon SJ. Association between Alcohol Consumption and Metabolic Syndrome Determined by Facial Flushing in Korean Women. Korean J Fam Med. 2020;10.4082/kjfm.19.0141. doi:10.4082/kjfm.19.0141.
Eshaghi FS, Ghazizadeh H, Kazami-Nooreini S, et al. Association of a genetic variant in AKT1 gene with features of the metabolic syndrome. Genes Dis. 2019;6(3):290–295. doi:10.1016/j.gendis.2019.03.002.
Yang X, Luo W, Han S, et al. Prevalence of high-risk coronary plaques in patients with and without metabolic syndrome and the relationship with prognosis. BMC Cardiovasc Disord. 2020;20(1):73. doi:10.1186/s12872-020-01358-8.
Kayal RA, Tsatsas D, Bauer MA, et al. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res. 2007;22(4):560–568. doi:10.1359/jbmr.070115.
Yamagishi S, Nakamura K, Inoue H. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med Hypotheses. 2005;65(6):1013–1015. doi:10.1016/j.mehy.2005.07.017.
Huang W, Shu L, Zhao H, Chen S, Zhang H, Song G. Association of the Triglyceride to High-Density Lipoprotein Ratio and the Visceral Adiposity Index with Metabolic Syndrome in Diabetic Susceptible Population. Horm Metab Res. 2020;52(2):95–103. doi:10.1055/a-1089-7991.
Kaneko K, Yatsuya H, Li Y, et al. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study. J Diabetes Investig. 2020;10.1111/jdi.13230. doi:10.1111/jdi.13230.
Horikawa K, Kasai Y, Yamakawa T, Sudo A, Uchida A. Prevalence of osteoarthritis, osteoporotic vertebral fractures, and spondylolisthesis among the elderly in a Japanese village. J Orthop Surg (Hong Kong). 2006;14(1):9–12. doi:10.1177/230949900601400103.
Chin KY, Ima-Nirwana S, Mohamed IN, et al. Insulin-like growth factor-1 is a mediator of age-related decline of bone health status in men. Aging Male. 2014;17(2):102–106. doi:10.3109/13685538.2014.896895.
Mohan S, Baylink DJ. Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol. 2005;185(3):415–420. doi:10.1677/joe.1.06141.
Riquelme-Gallego B, García-Molina L, Cano-Ibáñez N, et al. Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients. Sci Rep. 2020;10(1):1840. doi:10.1038/s41598-020-58760-7.
Kindblom JM, Ohlsson C, Ljunggren O, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24(5):785–791. doi:10.1359/jbmr.081234.
De Pergola G, Triggiani V, Bartolomeo N, et al. Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL Cholesterol. Endocr Metab Immune Disord Drug Targets. 2016;16(4):270–275. doi:10.2174/1871530317666170106150756.
García-Martín A, Cortés-Berdonces M, Luque-Fernández I, Rozas-Moreno P, Quesada-Charneco M, Muñoz-Torres M. Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause. 2011;18(5):537–541. doi:10.1097/gme.0b013e3181f8565e.
Bulló M, Moreno-Navarrete JM, Fernández-Real JM, Salas-Salvadó J. Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk. Am J Clin Nutr. 2012;95(1):249–255. doi:10.3945/ajcn.111.016642.
Kanazawa I, Yamaguchi T, Tada Y, Yamauchi M, Yano S, Sugimoto T. Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone. 2011;48(4):720–725. doi:10.1016/j.bone.2010.12.020.
Iki M, Tamaki J, Fujita Y, et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int. 2012;23(2):761–770. doi:10.1007/s00198-011-1600-7.
Movahed A, Larijani B, Nabipour I, et al. Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. J Bone Miner Metab. 2012;30(6):683–691. doi:10.1007/s00774-012-0367-z.
Sanchez-Enriquez S, Ballesteros-Gonzalez IT, Villafán-Bernal JR, et al. Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects. World J Diabetes. 2017;8(1):11–17. doi:10.4239/wjd.v8.i1.11.